Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated May 12, 2000, and published in the 
                    **Federal Register**
                     on June 2, 2000, (65 FR 35397), Sigma Aldrich Research Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: Drug
ScheduleCathinone (1235)
IMethcathinone (1237)
IAminorex (1585)
IAlpha-Ethyltryptamine (7249)
ILysergic acid diethylamide (7315)
ITetrahydrocannabinols (7370)
I4-Bromo-2, 5-dimethoxyam-
                             phetamine (7391)
I4-Bromo-2, 5-dimethoxyphen-
                             ethylamine (7392)
I2, 5-Dimethoxyamphetamine (7396)
I3, 4-Methylendioxyamphetamine (7400)
IN-Hydroxy-3, 4-methylenedioxy-
                             amphetamine (7402)
I3, 4-Methylenedioxy-N-ethylam-
                             phetamine (7404)
I3,4-Methylenedioxymethamphetamine (7405)
IPsilocybin (7437)
I1-[1- (2-Thienyl)cyclo-
                             hexyl]piperidine (7470)
IHeroin (9200)
INormorphine (9313)
IAmphetamine (1100)
IIMethamphetamine (1105)
IIPentobarbital (2270)
IIPhenylcyclohexylamine (7460)
IIPhencyclidine (7471)
IICocaine (9041)
IICodenine (9050)
IIDiprenorphine (9058)
IIBenzoylecgonine (9180)
IILevomethorphan (9210)
IILevorphanol (9220)
IIMeperidine (9230)
IIMetazocine (924)
IIMethadone (9250)
IIMorphine (9300)
IIThebaine (9333)
IILevo-alphacetylmethadol (LAAM) (9648)
IIFentanyl (9801)
II
 The firm plans to manufacture the listed controlled substances for laboratory reference standards and neurochemicals. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Sigma Aldrich Research Biochemicals, Inc. on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included 
                    ( print page 57624)
                    inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted. August 18, 2000. John H. King, Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration.


[FR Doc. 00-24562 Filed 9-22-00; 8:45 am] BILLING CODE 4410-09-M